David F. Hale, Director at BIOCEPT INC (BIOC), bought 50,000 shares at $1.00 ($50K) on 2016-05-04, disclosed to the SEC on 2016-05-05.
Open-market purchase of $50k BIOC by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| ONCT | SELL | 2021-07-02 | $17K | — | Filing → |
| BIOC | SELL | 2020-06-12 | $645 | — | Filing → |
| BIOC | BUY | 2016-10-21 | $200K | — | Filing → |